Brown Advisory Inc. Sells 78,909 Shares of Encompass Health Corporation (NYSE:EHC)

Brown Advisory Inc. trimmed its stake in Encompass Health Corporation (NYSE:EHC - Free Report) by 5.6% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,340,720 shares of the company's stock after selling 78,909 shares during the period. Brown Advisory Inc. owned approximately 1.33% of Encompass Health worth $135,788,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the stock. Colonial Trust Co SC bought a new position in shares of Encompass Health during the fourth quarter valued at approximately $29,000. Transce3nd LLC bought a new position in shares of Encompass Health during the fourth quarter valued at approximately $40,000. CBIZ Investment Advisory Services LLC grew its stake in shares of Encompass Health by 38.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock valued at $42,000 after buying an additional 127 shares during the last quarter. Signaturefd LLC grew its stake in shares of Encompass Health by 21.6% during the fourth quarter. Signaturefd LLC now owns 704 shares of the company's stock valued at $65,000 after buying an additional 125 shares during the last quarter. Finally, Arlington Trust Co LLC grew its stake in shares of Encompass Health by 22.9% during the first quarter. Arlington Trust Co LLC now owns 671 shares of the company's stock valued at $68,000 after buying an additional 125 shares during the last quarter. 97.25% of the stock is owned by institutional investors.

Encompass Health Stock Up 0.2%

Encompass Health stock opened at $119.22 on Tuesday. The firm has a market cap of $12.02 billion, a price-to-earnings ratio of 24.63, a price-to-earnings-growth ratio of 2.42 and a beta of 0.88. Encompass Health Corporation has a 52 week low of $82.74 and a 52 week high of $123.13. The business's 50-day moving average price is $119.46 and its 200 day moving average price is $105.70. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.81.

Encompass Health (NYSE:EHC - Get Free Report) last posted its earnings results on Thursday, April 24th. The company reported $1.37 EPS for the quarter, topping the consensus estimate of $1.19 by $0.18. The firm had revenue of $1.46 billion for the quarter, compared to analyst estimates of $1.43 billion. Encompass Health had a return on equity of 17.63% and a net margin of 8.97%. Encompass Health's revenue for the quarter was up 10.6% compared to the same quarter last year. During the same period last year, the company earned $1.12 earnings per share. As a group, sell-side analysts anticipate that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be issued a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 0.57%. The ex-dividend date is Tuesday, July 1st. Encompass Health's dividend payout ratio (DPR) is 14.05%.

Insider Buying and Selling at Encompass Health

In other Encompass Health news, insider Elissa Joy Charbonneau sold 4,279 shares of the firm's stock in a transaction that occurred on Tuesday, May 6th. The stock was sold at an average price of $116.61, for a total value of $498,974.19. Following the sale, the insider directly owned 11,958 shares of the company's stock, valued at approximately $1,394,422.38. This trade represents a 26.35% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Mark J. Tarr sold 118,384 shares of the firm's stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $121.53, for a total value of $14,387,207.52. Following the completion of the sale, the chief executive officer directly owned 527,070 shares in the company, valued at approximately $64,054,817.10. The trade was a 18.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 132,663 shares of company stock valued at $16,034,082. Company insiders own 2.10% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on EHC. Wall Street Zen cut Encompass Health from a "strong-buy" rating to a "buy" rating in a research note on Friday, June 6th. Barclays increased their price objective on Encompass Health from $118.00 to $129.00 and gave the stock an "overweight" rating in a research note on Friday, April 25th. Stephens raised Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price objective on the stock in a research note on Thursday, June 5th. KeyCorp upped their target price on Encompass Health from $122.00 to $135.00 and gave the stock an "overweight" rating in a report on Tuesday, May 27th. Finally, UBS Group upped their target price on Encompass Health from $117.00 to $130.00 and gave the stock a "buy" rating in a report on Monday, April 28th. Eight investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat.com, Encompass Health has an average rating of "Buy" and a consensus target price of $127.00.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corporation (NYSE:EHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.